Syon Capital’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2M Sell
4,219
-139
-3% -$70K 0.1% 148
2025
Q4
$2.03M Buy
4,358
+438
+11% +$203K 0.1% 151
2025
Q3
$1.67M Buy
3,920
+695
+22% +$269K 0.09% 151
2025
Q2
$1.24M Buy
3,225
+1,092
+51% +$393K 0.08% 174
2025
Q1
$737K Buy
2,133
+121
+6% +$38.9K 0.06% 235
2024
Q4
$604K Sell
2,012
-29
-1% -$10.1K 0.05% 246
2024
Q3
$830K Sell
2,041
-4
-0.2% -$1.46K 0.07% 199
2024
Q2
$657K Buy
2,045
+97
+5% +$31.5K 0.06% 216
2024
Q1
$650K Sell
1,948
-1,758
-47% -$537K 0.06% 225
2023
Q4
$1M Buy
3,706
+1,917
+107% +$474K 0.04% 260
2023
Q3
$440K Buy
+1,789
New +$490K 0.05% 201

Other funds holding HCA

Syon Capital's HCA Position: Q1 2026 in Review

Syon Capital reduced its HCA Healthcare (HCA) stake by 3.2% in Q1 2026, selling an estimated $70K and leaving 4,219 shares worth $2M. The position accounts for 0.1% of the portfolio, ranked #148.

Syon Capital first reported a position in HCA in Q3 2023 and has held it in 11 quarters since. The position peaked at $2.03M in Q4 2025. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.

  • Syon Capital held 4,219 shares of HCA Healthcare worth $2M as of Q1 2026.
  • Syon Capital sold 139 HCA Healthcare shares in Q1 2026, an estimated $70K.
  • HCA Healthcare made up 0.1% of Syon Capital's portfolio in Q1 2026, its #148 holding.
  • Syon Capital first reported a position in HCA Healthcare in Q3 2023 and has held it in 11 quarters since.
  • Syon Capital's HCA Healthcare position peaked at $2.03M in Q4 2025.
  • 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.

Based on Syon Capital's 13F filing for Q1 2026, filed 13 May 2026.